These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD1-positive epidermal Langerhans cells in regressed tuberculoid and lepromatous leprosy lesions. Narayanan RB; Girdhar A; Girdhar BK Int Arch Allergy Appl Immunol; 1990; 92(1):94-6. PubMed ID: 1700968 [TBL] [Abstract][Full Text] [Related]
3. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study. Bergfelt L Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956 [TBL] [Abstract][Full Text] [Related]
4. Langerhans cells (CD1a and CD207), dermal dendrocytes (FXIIIa) and plasmacytoid dendritic cells (CD123) in skin lesions of leprosy patients. Hirai KE; Aarão TL; Silva LM; de Sousa JR; de Souza J; Dias LB; Carneiro FR; Fuzii HT; Quaresma JA Microb Pathog; 2016 Feb; 91():18-25. PubMed ID: 26639680 [TBL] [Abstract][Full Text] [Related]
5. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. Sieling PA; Jullien D; Dahlem M; Tedder TF; Rea TH; Modlin RL; Porcelli SA J Immunol; 1999 Feb; 162(3):1851-8. PubMed ID: 9973451 [TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects. Smith CH; Allen MH; Groves RW; Barker JN Br J Dermatol; 1998 Aug; 139(2):239-46. PubMed ID: 9767237 [TBL] [Abstract][Full Text] [Related]
7. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293 [TBL] [Abstract][Full Text] [Related]
8. Repopulation of Langerhans cells during wound healing in an experimental human skin/SCID mouse model. Juhász I; Simon M; Herlyn M; Hunyadi J Immunol Lett; 1996 Sep; 52(2-3):125-8. PubMed ID: 8905406 [TBL] [Abstract][Full Text] [Related]
9. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies. Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752 [TBL] [Abstract][Full Text] [Related]
10. Lack of expression of intercellular adhesion molecule ICAM-1 in lepromatous leprosy patients. Moncada B; Torres-Alvarez MB; Gonzalez-Amaro R; Fuentes-Ahumada C; Baranda L; Delgado SP; Garcia R Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):581-5. PubMed ID: 7512116 [TBL] [Abstract][Full Text] [Related]
11. Nodular leprosy of childhood and tuberculoid leprosy: a comparative, morphologic, immunopathologic and quantitative study of skin tissue reaction. Fakhouri R; Sotto MN; Manini MI; Margarido LC Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):218-26. PubMed ID: 14608817 [TBL] [Abstract][Full Text] [Related]
12. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules. Moore PF; Schrenzel MD; Affolter VK; Olivry T; Naydan D Am J Pathol; 1996 May; 148(5):1699-708. PubMed ID: 8623937 [TBL] [Abstract][Full Text] [Related]
13. Multibacillary leprosy: lesions with macrophages positive for S100 protein and dendritic cells positive for Factor 13a. Cuevas-Santos J; Contreras F; McNutt NS J Cutan Pathol; 1998 Nov; 25(10):530-7. PubMed ID: 9870671 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of a cell-mediated reaction in the disposal of M. leprae in human skin. Kaplan G Immunol Lett; 1988 Nov; 19(3):223-7. PubMed ID: 3069709 [TBL] [Abstract][Full Text] [Related]
15. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity. Ashworth J; Kahan MC; Breathnach SM J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952 [TBL] [Abstract][Full Text] [Related]
16. Solar-simulating irradiation of the skin of human subjects in vivo produces Langerhans cell responses distinct from irradiation ex vivo and in vitro. Laihia JK; Jansen CT Exp Dermatol; 2000 Aug; 9(4):240-7. PubMed ID: 10949544 [TBL] [Abstract][Full Text] [Related]
17. NFκB transcription factor (p65) immunohistochemistry in leprosy dermal microvasculature. Silva LM; Hirai KE; de Sousa JR; de Souza J; Dias LB; Carneiro FRO; Aarão TLS; Fuzii HT; Quaresma JAS Microb Pathog; 2017 Dec; 113():427-431. PubMed ID: 29170041 [TBL] [Abstract][Full Text] [Related]
18. Effect of UVB 311 nm irradiation on normal human skin. Viac J; Goujon C; Misery L; Staniek V; Faure M; Schmitt D; Claudy A Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):103-8. PubMed ID: 9372527 [TBL] [Abstract][Full Text] [Related]
19. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. Hunger RE; Sieling PA; Ochoa MT; Sugaya M; Burdick AE; Rea TH; Brennan PJ; Belisle JT; Blauvelt A; Porcelli SA; Modlin RL J Clin Invest; 2004 Mar; 113(5):701-8. PubMed ID: 14991068 [TBL] [Abstract][Full Text] [Related]
20. Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae-BCG in lepromatous patients. Gross A; Weiss E; Tapia FJ; Aranzazu N; Gallinoto ME; Convit J Am J Trop Med Hyg; 1988 May; 38(3):608-12. PubMed ID: 2908581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]